Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery
- 1 March 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 33 (3) , 522-527
- https://doi.org/10.1067/mva.2001.111986
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trialThe Lancet, 2000
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial originAnnals of Neurology, 1997
- Assessment of a Bleeding Risk Index in Two Cohorts of Patients Treated with Oral AnticoagulantsThrombosis and Haemostasis, 1996
- Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart ValvesNew England Journal of Medicine, 1995
- Pharmacological prophylaxis against postoperative graft occlusion after peripheral vascular surgery: A world-wide surveyEuropean Journal of Vascular and Endovascular Surgery, 1995
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Prevention of one-year vein-graft occlusion after aortocoronary- bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulantsThe Lancet, 1993
- A Method to Determine the Optimal Intensity of Oral Anticoagulant TherapyThrombosis and Haemostasis, 1993
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1989
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988